The UN will soon unveil a new global science panel on #AMR - what can we do to make it effective and efficient? See the great papers from our conference in Lagos earlier this year: www.cgdev.org/project/buil...
The UN will soon unveil a new global science panel on #AMR - what can we do to make it effective and efficient? See the great papers from our conference in Lagos earlier this year: www.cgdev.org/project/buil...
Are you a researcher working in infectious diseases or #AMR, from a social science discipline (broadly interpreted?). INAMRSS has 3 great opportunities for you!
www.globalstrategylab.org/events/open-...
Abstract submission open now - move fast!
Issac Weldon from Univ Copenhagen describing what #AMR can learn from environmental governance www.youtube.com/watch?v=f4OS... based on our recent article w Kathleen Liddell (Univ Cambridge) in Milbank: pubmed.ncbi.nlm.nih.gov/40876865/
The world needs better science to fight drug-resistant infections. #amr
www.cgdev.org/blog/amr-pan...
How should the new Independent Panel on Evidence for Action on #AMR be set up? We gathered scientists and stakeholders - mainly from Africa - to think this through in Lagos, Nigeria. Pre-print now available:
verixiv.org/articles/2-2...
Another gem: "The widespread prevalence of genomic resistance elements observed, therefore, likely reflects intrinsic resistance elements rather than acquired or emergent resistance mechanisms."
Who should pay for #AMR innovation?
www.sciencedirect.com/science/arti...
@akesselheim.bsky.social
This time with #AMR
New funding opportunity opened today for Gram-negative antibacterial discovery (as late as LO) in therapeutics! gcgh.grandchallenges.org/challenge/in...
Welcome
Why destroy cancer research and cede global scientific leadership to China?
It is not clear how Harvard Law Review peer reviews student notes.
There might be many good reasons to strengthen such inspections, but is zoonotic transmission in USA a top tier risk that should be prioritized now? Iβd like to hear from experts on this.
This law student note presumes that important zoonotic jumps from animals to humans occur in the USA, leading to a recommendation to more tightly regulate live animal importation. For most salient examples, such as COVID and HIV/AIDS, zoonotic transmission was outside the USA.
Which lessons can be learned from prior international science panels? How can this help the new Independent Panel on Evidence for Action on AMR? www.cgdev.org/blog/chartin...
Great morning session on innovation here at this session led by Prof Sam Kariuki, KEMRI
Now Mingyuan Zhang on the Chinese role in the global antibiotic supply chain, with clever use of antidumping data and trade fairs in her anthropological work.
Next up was Mirza A Portillo, UC Dublin, on some unintended consequences of antibiotic narratives
@chddd.bsky.social Univ Vienna, spoke today at the British Academy on his research on the antibiotic pipeline, proposes a new triad of how we could think about success.
Great morning session on innovation here at this session led by Prof Sam Kariuki, KEMRI
Now Mingyuan Zhang on the Chinese role in the global antibiotic supply chain, with clever use of antidumping data and trade fairs in her anthropological work.
Next up was Mirza A Portillo, UC Dublin, on some unintended consequences of antibiotic narratives
@chddd.bsky.social Univ Vienna, spoke today at the British Academy on his research on the antibiotic pipeline, proposes a new triad of how we could think about success.
Dr Sonia Lewycka on equity discourse in AMR. Most AMR deaths are in lower income settings, so solutions must center equity. (Un)intended Consequences conf @ British Academy.
Nice way to transform Reviewer 2 comments into a paper!
The most amazingly painful episode of family holidays!
I also have concerns about the equities of this system
Academic Twitter found a new home. More Bluetorials, please. Any regrets from how the tenure system operates?
Do we have an AMR group?
Access to essential medicines is not improving over the past 4 decades with existing tools.
"The gap between richer (high- and upper-middle-income) and poorer (lower-middle- and low-income) countries remained largely unchanged over time."
www.healthaffairs.org/doi/epdf/10....